Showing results (321-330 of 523) with videos related to
Sort By:
Pageof 53
NPJ Precision Oncology|May 13, 2026
The novel ALK K1150dup mutation mediates resistance to frontline lorlatinib and retains sensitivity to gilteritinibMai Nagasaka, Francesco Facchinetti, Ludovic Bigot, et al.Clinical Lung Cancer|May 12, 2026
ENTRÉE Lung Platform Trial Sub-study 1: Phase II Randomized Efficacy and Safety Analysis of Feladilimab Plus Docetaxel Versus Docetaxel Monotherapy in Advanced/Recurrent NSCLCMarina Chiara Garassino, Sophie Cousin, Benjamin Besse, et al.BMC Cancer|July 16, 2016
Method for semi-automated microscopy of filtration-enriched circulating tumor cellsEmma Pailler, Marianne Oulhen, Fanny Billiot, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 7, 2014
An open-label, multicenter, randomized, phase II study of pazopanib in combination with pemetrexed in first-line treatment of patients with advanced-stage non-small-cell lung cancerGiorgio V Scagliotti, Enriqueta Felip, Benjamin Besse, et al.European Journal of Cancer (Oxford, England : 1990)|October 10, 2017
A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in patients with advanced non-small cell lung cancerJean-Charles Soria, Alex A Adjei, Rastilav Bahleda, et al.Lung Cancer (Amsterdam, Netherlands)|July 14, 2005
Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancerRafael Rosell, Yukito Ichinose, Miquel Taron, et al.JCO Precision Oncology|December 21, 2023
Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid CarcinomaJulien Hadoux, Abir Al Ghuzlan, Livia Lamartina, et al.Clinical Chemistry|January 12, 2017
Identification of ALK, ROS1, and RET Fusions by a Multiplexed mRNA-Based Assay in Formalin-Fixed, Paraffin-Embedded Samples from Advanced Non-Small-Cell Lung Cancer PatientsNoemí Reguart, Cristina Teixidó, Ana Giménez-Capitán, et al.Future Oncology (London, England)|May 7, 2014
Dynamic contrast-enhanced MRI parameters as biomarkers for the effect of vatalanib in patients with non-small-cell lung cancerFelix Nensa, Jörg Stattaus, Bruno Morgan, et al.Virchows Archiv : an International Journal of Pathology|February 25, 2021
Micronodular thymic carcinoma with lymphoid hyperplasia: relevance of immunohistochemistry with a small panel of antibodies for diagnosis-a RYTHMIC studyVincent Thomas de Montpreville, Audrey Mansuet-Lupo, Cécile Le Naoures, et al.Pageof 53